These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 22468875)
1. Payer management of oncology gets serious. Snyder M; Goldberg L; Ryan T Am J Manag Care; 2012 Feb; 18(1 Spec No.):SP6-7. PubMed ID: 22468875 [No Abstract] [Full Text] [Related]
2. Putting value into practice. Fendrick AM; de Souza J Am J Manag Care; 2012 Feb; 18(1 Spec No.):SP11. PubMed ID: 22468866 [No Abstract] [Full Text] [Related]
3. Managed care restrictions: barriers to product use in cancer care. Fox LA Am J Manag Care; 2013; 19(1 Spec No):SP24-5. PubMed ID: 23461469 [No Abstract] [Full Text] [Related]
4. The need for single-payer catastrophic health insurance. Bentivegna JF Conn Med; 1998 Apr; 62(4):237-40. PubMed ID: 9611420 [TBL] [Abstract][Full Text] [Related]
6. Robbing Peter to pay Paul? Financial reimbursement for chemotherapy. Arceci RJ J Pediatr Hematol Oncol; 2003 Apr; 25(4):277-8. PubMed ID: 12679638 [No Abstract] [Full Text] [Related]
7. Managed care & medical oncology: the focus is on value. Danielson E; Demartino J; Mullen JA J Natl Compr Canc Netw; 2010 Sep; 8 Suppl 7():S28-37. PubMed ID: 20947721 [TBL] [Abstract][Full Text] [Related]
8. Oncology pharmaceutical funding in New Zealand: a different approach and a proposal. Beatty PA; Laking GR J Oncol Pract; 2015 May; 11(3):249-51. PubMed ID: 25829524 [No Abstract] [Full Text] [Related]
9. Diametrically opposed. Vesely R Mod Healthc; 2011 May; 41(20):6-7, 16, 1. PubMed ID: 21717629 [TBL] [Abstract][Full Text] [Related]
10. The National Oncology Working Group (NOW) initiative: payer and provider collaborations in oncology benefits management. Soper AM; Reeder CE; Brown LM; Stojanovska A; Lennert BJ Am J Manag Care; 2010 Apr; 16(4):e94-7. PubMed ID: 20370311 [TBL] [Abstract][Full Text] [Related]
11. Ditching the single-payer system in the national health service: how the English Department of Health is learning the wrong lessons from the United States. Reynolds L; Gerada C; McKee M Int J Health Serv; 2012; 42(3):539-47. PubMed ID: 22993967 [TBL] [Abstract][Full Text] [Related]
12. Paul Keckley. Keckley P Nat Biotechnol; 2011 Mar; 29(3):185. PubMed ID: 21390004 [No Abstract] [Full Text] [Related]
13. Many new cancer drugs in the United Kingdom are facing negative NICE rulings. Low E; J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049 [No Abstract] [Full Text] [Related]
14. The promise and the pitfalls of reference pricing. Boland P Manag Care; 2014 May; 23(5):36-8. PubMed ID: 25016848 [No Abstract] [Full Text] [Related]
15. Use and coverage of novel cancer agents in managed care. Bailes JS Semin Oncol; 1994 Dec; 21(6 Suppl 14):34-7. PubMed ID: 7992098 [TBL] [Abstract][Full Text] [Related]
16. How to create successful alternative payment models in oncology. Miller HD Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP160-SP163. PubMed ID: 28665673 [No Abstract] [Full Text] [Related]
18. Health care stocks make slow recovery. Williams B Tenn Med; 1999 Apr; 92(4):121-2. PubMed ID: 10194977 [No Abstract] [Full Text] [Related]
19. Do the numbers add up for oral oncology quantity-limit programs? McCann T Manag Care; 2013 Jul; 22(7):33-5. PubMed ID: 23936971 [No Abstract] [Full Text] [Related]
20. National health care reform and a single-payer system: messiah or pariah? Norato JF J Health Hum Serv Adm; 1997; 19(3):341-56. PubMed ID: 10168172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]